Android app Apple app link

Drugs Made In America Acquisition Corp. Rights (DMAAR) Financials

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.20

$0.01 (2.63%)
Last update: 02:50 PM EST
Day's range
$0.19
Day's range
$0.2

DMAAR Income statement / Annual

Last year (2024), Drugs Made In America Acquisition Corp. Rights's total revenue was $0.00, and the percentage change from the previous year is not available. In 2024, Drugs Made In America Acquisition Corp. Rights's net income was -$479.00. See Drugs Made In America Acquisition Corp. Rights,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024
Period Ended 12/31/2024
Operating Revenue $0.00
Cost of Revenue $0.00
Gross Profit $0.00
Gross Profit Ratio 0
Research and Development Expenses $0.00
General & Administrative Expenses $479.73
Selling & Marketing Expenses $0.00
Selling, General & Administrative Expenses $479.73
Other Expenses $0.00
Operating Expenses $479.73
Cost And Expenses $479.73
Interest Income $0.00
Interest Expense $0.00
Depreciation & Amortization $479.73
EBITDA $0.00
EBITDA Ratio 0
Operating Income Ratio 0
Total Other Income/Expenses Net $0.00
Income Before Tax -$479.00
Income Before Tax Ratio 0
Income Tax Expense $0.00
Net Income -$479.00
Net Income Ratio 0
EPS -0.056
EPS Diluted -0.056
Weighted Average Shares Out $8.57 M
Weighted Average Shares Out Diluted $8.57 M
Link

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.